BE867727A - Nouveaux composes de phtalazine et composition pharmaceutique les contenant - Google Patents

Nouveaux composes de phtalazine et composition pharmaceutique les contenant

Info

Publication number
BE867727A
BE867727A BE188257A BE188257A BE867727A BE 867727 A BE867727 A BE 867727A BE 188257 A BE188257 A BE 188257A BE 188257 A BE188257 A BE 188257A BE 867727 A BE867727 A BE 867727A
Authority
BE
Belgium
Prior art keywords
phtalazine
compounds
new
pharmaceutical composition
composition containing
Prior art date
Application number
BE188257A
Other languages
English (en)
French (fr)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE867727A publication Critical patent/BE867727A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BE188257A 1977-06-03 1978-06-01 Nouveaux composes de phtalazine et composition pharmaceutique les contenant BE867727A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2358277 1977-06-03

Publications (1)

Publication Number Publication Date
BE867727A true BE867727A (fr) 1978-12-01

Family

ID=10198020

Family Applications (1)

Application Number Title Priority Date Filing Date
BE188257A BE867727A (fr) 1977-06-03 1978-06-01 Nouveaux composes de phtalazine et composition pharmaceutique les contenant

Country Status (29)

Country Link
US (1) US4289772A (de)
JP (1) JPS5416488A (de)
AR (2) AR222013A1 (de)
AT (2) AT362792B (de)
AU (1) AU505373B1 (de)
BE (1) BE867727A (de)
CA (1) CA1111850A (de)
DD (1) DD137355A5 (de)
DE (1) DE2824064A1 (de)
DK (1) DK248078A (de)
EG (1) EG13527A (de)
ES (4) ES470470A1 (de)
FI (1) FI781753A (de)
FR (1) FR2392986A1 (de)
GB (1) GB2000136B (de)
GR (1) GR74402B (de)
HU (1) HU179745B (de)
IL (1) IL54842A (de)
IN (3) IN148482B (de)
IT (1) IT1094944B (de)
LU (1) LU79761A1 (de)
NL (1) NL7806016A (de)
NO (1) NO781935L (de)
NZ (1) NZ187453A (de)
PL (3) PL116437B1 (de)
PT (1) PT68126A (de)
SE (1) SE7806519L (de)
SU (2) SU856383A3 (de)
ZA (1) ZA783183B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
IL59619A0 (en) * 1979-03-28 1980-06-30 Pfizer Phthalazine derivatives,their preparation and pharmaceutical compositions containing them
GR73576B (de) * 1980-03-01 1984-03-20 Wyeth John & Brother Ltd
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
US4882354A (en) * 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
JP3169188B2 (ja) * 1991-01-31 2001-05-21 杏林製薬株式会社 カルバミン酸誘導体及びその製造方法
US5300515A (en) * 1991-01-31 1994-04-05 Kyorin Pharmaceutical Co., Ltd. Carbamic acid derivatives and method for preparing the same
EP0621267A1 (de) * 1993-04-07 1994-10-26 Shell Internationale Researchmaatschappij B.V. Spiropiperidinderivate und ihre Verwendung als Fungizide
AU5772196A (en) * 1995-05-19 1996-11-29 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU722710B2 (en) * 1996-08-20 2000-08-10 Eisai Co. Ltd. Remedies for erectile dysfunction containing fused pyridazine compounds
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
US20040224986A1 (en) * 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
AU2003259891A1 (en) * 2002-08-16 2004-03-19 Janssen Pharmaceutica N.V. Piperidinyl compounds that selectively bind integrins
US20060019975A1 (en) * 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
EP2275095A3 (de) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenese durch modulation des Muscarinrezeptors
EP2258358A3 (de) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
BRPI0707223A2 (pt) * 2006-01-27 2011-04-26 Pfizer Prod Inc compostos de derivados de aminoftalazina
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US8247442B2 (en) 2006-03-29 2012-08-21 Purdue Pharma L.P. Benzenesulfonamide compounds and their use
WO2007118854A1 (en) 2006-04-13 2007-10-25 Euro-Celtique S.A. Benzenesulfonamide compounds and the use thereof
TW200815353A (en) 2006-04-13 2008-04-01 Euro Celtique Sa Benzenesulfonamide compounds and their use
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
EP1900731A1 (de) * 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren
EP1903037A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors
KR20090064418A (ko) 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US8399486B2 (en) 2007-04-09 2013-03-19 Purdue Pharma L.P. Benzenesulfonyl compounds and the use thereof
CN101778837A (zh) 2007-08-07 2010-07-14 弗·哈夫曼-拉罗切有限公司 作为nk3受体拮抗剂的吡咯烷芳基-醚
EP2190815B1 (de) 2007-08-22 2011-08-10 F. Hoffmann-La Roche AG Pyrrolidinarylether als nk3-rezeptorantagonisten
KR101174980B1 (ko) * 2007-09-14 2012-08-17 에프. 호프만-라 로슈 아게 Ｎｋ３ 수용체 길항제로서의 피페리딘 유도체
US8765736B2 (en) 2007-09-28 2014-07-01 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AR077014A1 (es) 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
CN113087654B (zh) * 2021-04-15 2022-12-23 苏州昊帆生物股份有限公司 哌啶-4-丁胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1094044A (en) * 1965-07-12 1967-12-06 Vantorex Ltd Phthalazine derivatives
GB1199768A (en) 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
GB1460389A (en) 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Also Published As

Publication number Publication date
HU179745B (en) 1982-12-28
US4289772A (en) 1981-09-15
ES478199A1 (es) 1980-01-16
FI781753A (fi) 1978-12-04
NO781935L (no) 1978-12-05
AR223999A1 (es) 1981-10-15
ES478201A1 (es) 1980-02-01
ZA783183B (en) 1979-06-27
PL207337A1 (pl) 1979-06-04
ES478200A1 (es) 1980-01-01
ATA400878A (de) 1980-11-15
DE2824064A1 (de) 1978-12-14
AR222013A1 (es) 1981-04-15
FR2392986B1 (de) 1982-07-16
DD137355A5 (de) 1979-08-29
IT1094944B (it) 1985-08-10
DK248078A (da) 1978-12-04
PL116437B1 (en) 1981-06-30
GB2000136A (en) 1979-01-04
IN148482B (de) 1981-03-07
SE7806519L (sv) 1978-12-04
NL7806016A (nl) 1978-12-05
JPS5538351B2 (de) 1980-10-03
JPS5416488A (en) 1979-02-07
PT68126A (en) 1978-07-01
PL116420B1 (en) 1981-06-30
SU856383A3 (ru) 1981-08-15
CA1111850A (en) 1981-11-03
GR74402B (de) 1984-06-28
AT362792B (de) 1981-06-10
PL113208B1 (en) 1980-11-29
AU505373B1 (en) 1979-11-15
IN149973B (de) 1982-06-19
AT363096B (de) 1981-07-10
LU79761A1 (fr) 1980-01-22
IT7824106A0 (it) 1978-06-01
IN149550B (de) 1982-01-16
FR2392986A1 (fr) 1978-12-29
SU862826A3 (ru) 1981-09-07
NZ187453A (en) 1980-12-19
IL54842A (en) 1982-01-31
ATA305080A (de) 1980-12-15
GB2000136B (en) 1982-01-06
IL54842A0 (en) 1978-08-31
EG13527A (en) 1981-12-31
ES470470A1 (es) 1979-09-01

Similar Documents

Publication Publication Date Title
BE867727A (fr) Nouveaux composes de phtalazine et composition pharmaceutique les contenant
BE876732A (fr) Nouveaux aminothiazoles et composition pharmaceutique les contenant
BE867248A (fr) Nouveaux isomeres dextrogyres de spiro-hydantoines asymetriques et compositions pharmaceutiques les contenant
LU80795A1 (fr) Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant
BE859824A (fr) Nouveaux derives d'hydantoine et composition pharmaceutique les contenant
BE871907A (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et medicament les contenant
LU78330A1 (fr) Procede de preparation de nouveaux derives d'hydantoine et de composition pharmaceutique les contenant
FR2345450A1 (fr) Quinoxalinones et quinoxalines, leurs procedes de preparation et composition pharmaceutique les contenant
BE880065A (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
BE870402A (fr) Nouveaux phenols a substituant hydroxyalkyle ou oxoalkyle et composition pharmaceutique les contenant
BE870403A (fr) Nouveaux 3-(2-hydroxy-4(substituant)-phenyl)-azacyclo-alcanes et medicament les contenant
BE868366A (fr) Nouveaux composes du phosphore et compositions ignifuges les contenant
FR2283686A1 (fr) Nouveaux composes heterocycliques et compositions pharmaceutiques les contenant
BE871623A (fr) Nouveaux derives du tetrazole et compositions pharmaceutiques les contenant
FR2331339A1 (fr) Nouveaux composes heterocycliques et composition pharmaceutique les contenant
BE885389A (fr) Composes penam acetoxymethyles et composition pharmaceutique les contenant
FR2349585A1 (fr) Nouveau derive de xanthine et composition pharmaceutique le contenant
FR2446819B1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
BE855022A (fr) Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant
FR2450814B1 (fr) 24,24-difluoro-25-hydroxycholecalciferol et composition pharmaceutique renfermant ce produit
BE863620A (fr) Nouveaux derives 4"-amines d'oleandomycine et medicaments les contenant
BE885709A (fr) Nouveaux composes heterocycliques azotes anti-inflammatoires et immunoregulateurs et composition pharmaceutique les contenant
BE832725A (fr) Nouveaux composes meterocycliques et composition pharmaceutique les contenant
FR2329281A1 (fr) Nouveaux 6,8-dioxamorphinanes n-substitues et composition pharmaceutique les contenant
FR2528425B1 (fr) 1,4-dihydropyridines et composition pharmaceutique les contenant